# REVIVE Prospective Registry Cohort Study

> **NCT07429890** · — · NOT_YET_RECRUITING · sponsor: **Peter Belafsky, MD** · enrollment: 31 (estimated)

## Conditions studied

- Oropharyngeal Dysphagia

## Interventions

- **OTHER:** Other: No Intervention (subjects were previously treated with Iltamiocel). This is a observational study and all participants will be observed with no intervention.

## Key facts

- **NCT ID:** NCT07429890
- **Lead sponsor:** Peter Belafsky, MD
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-30
- **Primary completion:** 2031-06-30
- **Final completion:** 2032-06-30
- **Target enrollment:** 31 (ESTIMATED)
- **Last updated:** 2026-04-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07429890

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07429890, "REVIVE Prospective Registry Cohort Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07429890. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*